Bio Pharma Market in India 2017

The latest market research report titled Bio Pharma Market in India 2017 states that while historically the biopharmaceuticals market in the country grew at a CAGR of 15.7%, it is expected to grow at a CAGR of 13.6% between 2016 and 2022. With a large portion of the population falling in the senior citizen category, the need for various healthcare services and pharmaceutical products, including biopharmaceuticals is expected to rise in the country. Moreover, with increased life expectancy, this segment of the population is expected to grow further in the coming years. The increased disposable income of Indians is also allowing them to spend more on medicines and follow medication more diligently. Also, growing health awareness among individuals is resulting in early detection of various medical conditions, and leading to individuals being subject to various medications much earlier than before.
However, the lack of regulatory clarity acts as a major challenge for the industry. The regulation of biopharmaceuticals is inefficient and complex due to the involvement of multiple agencies and committees in the review and approval process. Competition from other Asian countries also acts as a challenge for the Indian bio pharma market. Despite the competition from other countries, Indias biotechnology sector has attracted major investments from several global companies due to its strong generic biotechnology potential. While Indian Immunologicals Ltd. set up vaccine manufacturing facilities in Pondicherry and Hyderabad by investing INR 3 bn and INR 2.5 bn respectively, Shantha Biotechnics Pvt. Ltd. built an insulin product manufacturing facility entailing an investment of INR 4.6 bn. The country is being recognized globally as a preferred outsourcing destination for contract research and manufacturing services. This will further aid in the development of the countrys bio pharma sector. Biocon Ltd., Dr. Reddys Laboratories Ltd, Serum Institute of India Pvt. Ltd., Lupin Ltd. and Intas Pharmaceuticals Ltd. are some of the major companies operating in this market.

Coverage:
Overview of the bio pharma market in India, and historical and forecasted market size data over 2010 to 2022
Trade analysis of bio pharma products in India
Qualitative analysis of the major drivers and challenges affecting the market
Analysis of the competitive landscape and profiles of major players operating in the market
Key recent developments in the Indian bio pharma sector

Why Buy:
Get a broad understanding of the bio pharma sector in India, the dynamics of the market and the current state of the sector
Strategize marketing, market-entry, market expansion and other business plans by understanding the factors driving the growth of the market
Be informed regarding the key developments in the Indian bio pharma sector
Understand major competitors business and market dynamics, and respond accordingly

Slide 1: Executive Summary

Socioeconomic Indicators
Slide 2: Total Population (2010-2011 2019-2020), Population Density (2010-2011 2019-2020)
Slide 3: Sex Ratio (2005, 2010, 2015, 2020), Population by Age Group (2005, 2010, 2015, 2020), Urbanization Trend (2010-2011 2019-2020)
Slide 4: Total Fertility Rate (2005-2010, 2010-2015, 2015-2020), Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020), Total Number of Births (2005-2010, 2010-2015, 2015-2020), Total Number of Death (2005-2010, 2010-2015, 2015-2020)
Slide 5: Total Literacy Rate (2001, 2011), Rural Literacy (2001, 2011), Urban Literacy (2001, 2011)
Slide 6: GDP at Market Prices (2010-2014), FDI (2010-2014), Inflation Rate (2010-2014), Unemployment Rate (2010-2014)
Slide 7: Access to Safe Drinking Water (2001, 2011), Exchange Rate (2010-2015)

Market Overview
Slide 8: Market Definition & Structure
Slide 9: Biopharmaceuticals Market in India Market Size & Growth (2010 2022)
Slide 10: Biopharmaceuticals Market in India Market Overview
Slide 11: Porters Five Forces Analysis

Trade Analysis
Slide 12: Export of Vaccines for Human Medicine Size (Value-Wise; FY 2013 FY 2017 and Volume-Wise; FY 2013 FY 2017)
Slide 13: Export of Vaccines for Human Medicine Country-Wise Segmentation (Value-Wise; FY 2015 and FY 2016; and Volume-Wise; FY 2015 and FY 2016)
Slide 14: Import of Vaccines for Human Medicine Size (Value-Wise; FY 2013 FY 2017 and Volume-Wise; FY 2013 FY 2017)
Slide 15: Import of Vaccines for Human Medicine Country-Wise Segmentation (Value-Wise; FY 2015 and FY 2016; and Volume-Wise; FY 2015 and FY 2016)

Market Influencers
Slide 16-17: Market Drivers
Slide 18: Market Challenges

Market Trends
Slide 19: Key Trends

Competitive Landscape
Slide 20: List of Major Players
Slide 21-50: Profiles of Major Players

Recent Developments
Slide 51-52: Recent Developments

Appendix
Slide 53: Research Methodology

List Of Tables

Competitive Landscape
1. List of Major Players
2. Key Financial Performance Indicators (only Public Companies)
3. Key Ratios (only Public Companies)

List Of Figures

Socioeconomic Indicators
1. Total Population and Population Density (2010-2011 2019-2020)
2. Sex Ratio (2005, 2010, 2015, 2020)
3. Population by Age Group (2005, 2010, 2015, 2020)
4. Urbanization Trend (2010-2011 2019-2020)
5. Total Fertility Rate (2005-2010, 2010-2015, 2015-2020)
6. Infant Mortality Rate (2005-2010, 2010-2015, 2015-2020)
7. Total number of Births (2005-2010, 2010-2015, 2015-2020)
8. Total number of Death (2005-2010, 2010-2015, 2015-2020)
9. Total Literacy Rate (2001, 2011)
10. Rural Literacy (2001, 2011)
11. Urban Literacy (2001, 2011)
12. GDP at Market Prices (2010-2014)
13. FDI (2010-2014)
14. Inflation Rate (2010-2014)
15. Unemployment Rate (2010-2014)
16. Access to safe drinking water (2001, 2011)
17. Exchange Rate (2010-2015)

Market Overview
1. Biopharmaceuticals Market in India Historical Market Size & Growth (Value-Wise; 2010 2026)
2. Biopharmaceuticals Market in India Forecasted Market Size & Growth (Value-Wise; 2016 2022e)


Trade Analysis
1. Export of Vaccines for Human Medicine Size (Value-Wise; FY 2013 FY 2017)
2. Export of Vaccines for Human Medicine Size (Volume-Wise; FY 2013 FY 2017)
3. Country-Wise Exports of Vaccines for Human Medicine (Value-Wise: FY 2016)
4. Country-Wise Exports of Vaccines for Human Medicine (Value-Wise: FY 2017)
5. Country-Wise Exports of Vaccines for Human Medicine (Volume-Wise: FY 2016)
6. Country-Wise Exports of Vaccines for Human Medicine (Volume-Wise: FY 2017)
7. Import of Vaccines for Human Medicine Size (Value-Wise; FY 2013 FY 2017)
8. Import of Vaccines for Human Medicine Size (Volume-Wise; FY 2013 FY 2017)
9. Country-Wise Imports of Vaccines for Human Medicine (Value-Wise: FY 2016)
10. Country-Wise Imports of Vaccines for Human Medicine (Value-Wise: FY 2017)
11. Country-Wise Imports of Vaccines for Human Medicine (Volume-Wise: FY 2016)
12. Country-Wise Imports of Vaccines for Human Medicine (Volume-Wise: FY 2017)

Competitive Landscape
1. Financial Snapshot Total Income and Net Profit/Loss (only Public Companies)
2. Key Business Segments (only Public Companies)
3. Key Geographic Segments (only Public Companies)

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available